These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8535713

  • 1. Immunohistochemical analysis of nm23 protein in transitional cell carcinoma of the bladder.
    Shiina H, Igawa M, Urakami S, Shirakawa H, Ishibe T.
    Br J Urol; 1995 Dec; 76(6):708-13. PubMed ID: 8535713
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H, Igawa M, Nagami H, Yagi H, Urakami S, Yoneda T, Shirakawa H, Ishibe T, Kawanishi M.
    Cancer; 1996 Oct 15; 78(8):1762-74. PubMed ID: 8859190
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical evaluation of nm23-H1 gene product in transitional cell carcinoma of the bladder.
    Nakopoulou LL, Constandinides CA, Tzonou A, Lazaris AC, Zervas A, Dimopoulos CA.
    Histopathology; 1996 May 15; 28(5):429-35. PubMed ID: 8735718
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemistry of p53 protein in transitional-cell carcinoma of the bladder using an image analyzer.
    Shiina H, Igawa M, Yagi H, Urakami S, Yoneda T, Shirakawa H, Ishibe T.
    Oncology; 1996 May 15; 53(3):233-40. PubMed ID: 8643227
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
    Krause FS, Feil G, Bichler KH.
    Anticancer Res; 2000 May 15; 20(6D):5023-8. PubMed ID: 11326661
    [Abstract] [Full Text] [Related]

  • 6. Biological characteristics of inverted papilloma of the urinary bladder.
    Urakami S, Igawa M, Shirakawa H, Shiina H, Ishibe T.
    Br J Urol; 1996 Jan 15; 77(1):55-60. PubMed ID: 8653317
    [Abstract] [Full Text] [Related]

  • 7. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
    Alderisio M, Cenci M, Valli C, Russo A, Bazan V, Dardanoni G, Cucciarre S, Carreca I, Macaluso MP, Tomasino RM, Vecchione A.
    Anticancer Res; 1998 Jan 15; 18(6A):4225-30. PubMed ID: 9891471
    [Abstract] [Full Text] [Related]

  • 8. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features.
    Lee CC, Yamamoto S, Morimura K, Wanibuchi H, Nishisaka N, Ikemoto S, Nakatani T, Wada S, Kishimoto T, Fukushima S.
    Cancer; 1997 Feb 15; 79(4):780-9. PubMed ID: 9024716
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
    Shiina H, Igawa M, Urakami S, Honda S, Shirakawa H, Ishibe T.
    J Clin Pathol; 1996 May 15; 49(5):395-9. PubMed ID: 8707954
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical analysis of nm23-H1 protein in bladder cancer.
    Kuo JY, Chiang H, Chen KK, Chang LS.
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul 15; 62(7):411-7. PubMed ID: 10418173
    [Abstract] [Full Text] [Related]

  • 11. Relationship of serum testosterone level with proliferating cell nuclear antigen and nm23 protein in human prostatic carcinoma tissue.
    Shiina H, Igawa M, Shigeno K, Wada Y, Yoneda T, Yagi H, Shirakawa R, Nagasaki M.
    Oncology; 1997 Jul 15; 54(6):482-9. PubMed ID: 9394845
    [Abstract] [Full Text] [Related]

  • 12. Relationship of genetic instability with immunoreactivities for p53 protein and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder.
    Shiina H, Igawa M, Yagi H, Urakami S, Shirakawa H, Ishibe T.
    Eur Urol; 1996 Jul 15; 30(1):80-8. PubMed ID: 8854073
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical analysis of estramustine binding protein with particular reference to proliferative activity in human prostatic carcinoma.
    Shiina H, Igawa M, Shigeno K, Wada Y, Yoneda T, Shirakawa H, Ishibe T, Shirakawa R, Nagasaki M, Shirane T, Usui T.
    Prostate; 1997 Jun 15; 32(1):49-58. PubMed ID: 9207957
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical analysis of nm23 protein in transitional cell carcinoma of the bladder.
    Brewster SF, Gingell JC.
    Br J Urol; 1996 Aug 15; 78(2):321-2. PubMed ID: 8813946
    [No Abstract] [Full Text] [Related]

  • 15. The role of nm23-H1 in the progression of transitional cell bladder cancer.
    Chow NH, Liu HS, Chan SH.
    Clin Cancer Res; 2000 Sep 15; 6(9):3595-9. PubMed ID: 10999750
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quantitative analysis of NM23 protein immunoreactivity in renal cell carcinoma using an image analyzer.
    Urakami S, Igawa M, Shirakawa H, Shiina H, Kawanishi M.
    J Urol; 1997 May 15; 157(5):1928-31. PubMed ID: 9112565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.